GSK details hopes for 14 pipeline drugs in 2013-14

LONDON (Reuters) - GlaxoSmithKline expects to have pivotal clinical trial results on up to 14 medicines in the next two years, including two new products which - if they work - could change the way cancer and heart disease are treated.

via Reuters: Health News Read More Here..